Education Center

The Role of Hysteroscopy in Minimally Invasive Management of Intrauterine Health

A supplement to OBG Management. This supplement is sponsored by Boston Scientific.

 

This supplement highlights the benefits of using the Symphion™ Tissue Removal System for diagnostic and operative hysteroscopy.  

 

Faculty/Faculty Disclosure

Linda D. Bradley, MD

Obstetrics, Gynecology and Women’s

  Health Institute,

Cleveland Clinic,

Cleveland, Ohio, USA

 

Competing Interest and Financial Disclosures:   Dr. Bradley reports that she has received grant/research/clinical trial support from Bayer Healthcare Pharmaceuticals Inc. She is a consultant and on the advisory board for Bayer Healthcare Pharmaceuticals Inc., Boston Scientific Corporation, and Smith & Nephew; she is on the advisory board for Patient-Centered Outcomes Research Institute; she is on the speakers' bureau for Smith & Nephew (Medtronic); she is on the scientific advisory panel for Karl Storz; and she is on the data safety and monitoring board for Gynesonics. 

Recommended for You

Reviews and Expert Commentary

Quizzes from MD-IQ

Research Summaries from ClinicalEdge

Next Article: